NCT05281809
- Conditions
- B Acute Lymphoblastic Leukemia, B-cell Lymphoma, Burkitt Lymphoma, +36 more
- Locations
-
- AHN Cancer Institute - West Penn Hospital Pittsburgh, Pennsylvania, United States
Clinical trial condition
B-cell Lymphoma
Explore clinical trials studying B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
84 public trials
25 recruiting studies
B-cell Lymphoma trial results
Recruiting
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
NCT06758713
- Conditions
- B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- The Third Affiliated Hospital of Southern Medical University Guangzhou, Guangdong, China
NCT06002659
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Karolinska University Hospital Stockholm, Sweden
- Uppsala University Hospital Uppsala, Sweden
NCT06081478
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Burkitt Lymphoma, +18 more
- Locations
-
- Liang Wang Beijing, Beijing Municipality, China
NCT03787056
- Conditions
- Adnexal Diseases, Astrocytoma, B-cell Lymphoma, +89 more
- Locations
-
- Service de NEURO-ONCOLOGIE du Groupement Hospitalier EST Bron, France
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'hôpital de la Croix-Rousse Lyon, France
- Service d'ONCOLOGIE DIGESTIVE et HEPATOLOGIE de l'Hôpital E. Herriot Lyon, France
- Service d'Oto-Rhino-Laryngologie de l'Hôpital de la Croix-Rousse Lyon, France
Not yet recruiting
Phase I Study of FXS0683 in the Treatment of Blood Tumors
NCT07616089
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma, +18 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) Tianjin, Tianjin Municipality, China
Not yet recruiting
Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
NCT07593482
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Kantonsspital Aarau Aarau, Switzerland
- Universitätsspital Basel Basel, Switzerland
- Ente Ospedaliero Cantonale (EOC)-Istituto Oncologico della Svizzera Italiana (IOSI) Bellinzona, Switzerland
- Inselspital Bern - Universitätsklinik für Medizinische Onkologie Bern, Switzerland
Enrolling by invitation
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
NCT07168486
- Conditions
- B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
- Locations
-
- University of Maryland, Baltimore Baltimore, Maryland, United States
Enrolling by invitation
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
NCT07474051
- Conditions
- AML (Acute Myelogenous Leukemia), B-cell Lymphoma, Chronic Disease, +33 more
- Locations
-
- Charité Universitätsmedizin Berlin Berlin, Germany
- Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus Dresden, Germany
- Universitätsklinikum Marburg Marburg, Germany
- Klinikum der Universität (LMU) Muenchen Munich, Germany
Active, not recruiting
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
NCT05934838
- Conditions
- B-cell Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +14 more
- Locations
-
- Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States